Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
SYN-010 in breath methane-positive IBS-C
NCT02495623Phase 2Completed
- Sponsor
- Theriva Biologics
- Start
- Jun 2015
- Primary completion
- Oct 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of SYN-010 in irritable bowel syndrome (IBS), sponsored by Theriva Biologics. Started Jun 2015; status: completed.
02
Drugs
SYN-010
03
Conditions
irritable bowel syndrome (IBS)
Beyond the preview
Go deeper on NCT02495623.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02495623.